Filing Details
- Accession Number:
- 0001181431-12-026768
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-01 17:09:24
- Reporting Period:
- 2012-04-27
- Filing Date:
- 2012-05-01
- Accepted Time:
- 2012-05-01 17:09:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1454983 | S Richard Levy | Experimental Station Route 141 And Henry Clay Rd Wilmington DE 19880 | Evp, Chief Drug Dev&Medical Of | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-04-27 | 11,809 | $8.99 | 11,809 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-04-27 | 9,751 | $8.99 | 21,560 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-04-27 | 8,440 | $8.19 | 30,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-04-27 | 30,000 | $22.95 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-04-27 | 11,809 | $0.00 | 11,809 | $8.99 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-04-27 | 9,751 | $0.00 | 9,751 | $8.99 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-04-27 | 8,440 | $0.00 | 8,440 | $8.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-01-17 | No | 4 | M | Direct | |
| 38,440 | 2015-01-17 | No | 4 | M | Direct | |
| 0 | 2014-02-12 | No | 4 | M | Direct |
Footnotes
- Beginning January 18, 2005, options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remaining vesting monthly over three years.
- Beginning February 13, 2004, options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remaining vesting monthly over three years.
- These transactions were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Billionaire Hedge Funds
